Moreover, experimental evidence demonstrates that ROS1G2032R induces epithelial-mesenchymal transition and amplifies the migratory and invasive capacities of ROS1 fusion-driven cancer cells through the upregulation of Twist1 (136). Here, ROS1 is linked to cancer.